Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old, of any gender or ethnicity
- People on dialysis or not yet on dialysis who have recently had a new wrist fistula (a surgically created connection between an artery and vein in the wrist) created but have not yet used it for dialysis treatment
- People whose pre-surgery ultrasound showed specific measurements of the wrist artery and vein that meet the trial's size and depth requirements (confirm with trial site)
- People whose dialysis will use a specific calcium level in the dialysis fluid and a specific type of blood thinner called low molecular weight heparin, kept at a consistent dose throughout the study
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People whose fistula surgery wound is not healing well
- People with an active bacterial or viral infection
- People who are pregnant
- People who receive a kidney transplant or switch to a different type of dialysis (peritoneal dialysis) during the study period
- People with significantly elevated liver enzyme levels (ALT or AST) on blood tests (confirm with trial site)
- People with moderate to severe heart failure (classified as NYHA level III or IV) within the past 3 months
- People who have been newly diagnosed with unstable chest pain (angina) or had a stroke or related brain blood vessel event within the past 3 months
- People whose blood pressure has been too low (below 90/60 mmHg) or too high (above 180/100 mmHg) in the past 2 weeks
- People who have changed the type or dose of blood-thinning or clot-preventing medications (such as aspirin or clopidogrel) without medical advice during the study
- People currently taking steroid medications or immune-suppressing drugs such as tacrolimus, cyclosporine, or similar medications
- People with a serious condition such as cancer where life expectancy is estimated at less than 6 months
- People who have taken part in another clinical trial within the 4 weeks before this study begins
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiangqing Kong, Suzhou Municipal Hospital
Phone: +8618901547679
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maturity rate of arteriovenous fistula; Maturity rate of arteriovenous fistula
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.